# Carl Zeiss Meditec to acquire D.O.R.C. from Eurazeo

Carl Zeiss Meditec AG has agreed to acquire 100% of Dutch Ophthalmic Research Center (D.O.R.C.) from Eurazeo SE. The acquisition will expand Zeiss's position in vitreo-retinal surgery.

- Type: Acquisition
- Announced: 2023-12-15
- Where: Netherlands
- Value: $1.09B (985.0M EUR)
- Status: announced
- Products: retinal surgical devices, EVA NEXUS platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eurazeo](https://endata.com/companies/25357.md) (partner)
- [Carl Zeiss Meditec AG](https://endata.com/companies/26394.md) (acquirer)
- [Dutch Ophthalmic Research Center (D.O.R.C.)](https://endata.com/companies/74451.md) (target)
- [Dutch Ophthalmic Research Center (International) B.V.](https://endata.com/companies/74462.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/carl-zeiss-meditec-ag-announces-agreement-to-acquire-dutch-ophthalmic-research-center-dorc-302017022.html), 2023-12-15: "Carl Zeiss Meditec AG announced today that it has entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center (International) B.V. (D.O.R.C.) from the investment firm Eurazeo SE."
- [ophthalmologytimes.com](https://www.ophthalmologytimes.com/view/carl-zeiss-meditec-ag-to-acquire-dutch-ophthalmic-research-center), 2023-12-15: "With the acquisition of Dutch Ophthalmic Research Center, we’ll bring together two highly innovative ophthalmic powerhouses to accelerate ZEISS’s position in the vitreo-retinal surgery segment and extend our leadership in the ophthalmic medical devices market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.